+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Non-Hodgkin Lymphoma - Pipeline Review, H2 2019

  • ID: 4894231
  • Drug Pipelines
  • December 2019
  • Region: Global
  • 3240 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 3SBio Inc
  • Affimed GmbH
  • Anew Oncology Inc
  • AUM Biosciences Pte Ltd
  • BioLineRx Ltd
  • Carrick Therapeutics Ltd
  • MORE
Non-Hodgkin Lymphoma - Pipeline Review, H2 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2019, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

Non-Hodgkin lymphoma (also known as non-Hodgkin's lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body's immune system. Symptoms depend on what area of the body is affected by the cancer and how fast the cancer is growing. Symptoms may include night sweats (soaking the bed sheets and pajamas even though the room temperature is not too hot),fever and chills that come and go, itching, swollen lymph nodes in the neck, underarms, groin, or other areas, weight loss, coughing or shortness of breath if the cancer affects the thymus gland or lymph nodes in the chest, putting pressure on the windpipe (trachea) or other airway, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if the cancer affects the brain. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Non-Hodgkin Lymphoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Non-Hodgkin Lymphoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Hodgkin Lymphoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 20, 1, 35, 193, 179, 3, 17, 163, 21 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 20, 25, 1, 35, 4 and 1 molecules, respectively.

Non-Hodgkin Lymphoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Non-Hodgkin Lymphoma (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Non-Hodgkin Lymphoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Non-Hodgkin Lymphoma (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Non-Hodgkin Lymphoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Non-Hodgkin Lymphoma (Oncology)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Non-Hodgkin Lymphoma (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Non-Hodgkin Lymphoma (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3SBio Inc
  • Affimed GmbH
  • Anew Oncology Inc
  • AUM Biosciences Pte Ltd
  • BioLineRx Ltd
  • Carrick Therapeutics Ltd
  • MORE
Introduction
Non-Hodgkin Lymphoma - Overview
Non-Hodgkin Lymphoma - Therapeutics Development
Non-Hodgkin Lymphoma - Therapeutics Assessment
Non-Hodgkin Lymphoma - Companies Involved in Therapeutics Development
Non-Hodgkin Lymphoma - Drug Profiles
Non-Hodgkin Lymphoma - Dormant Projects
Non-Hodgkin Lymphoma - Discontinued Products
Non-Hodgkin Lymphoma - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Non-Hodgkin Lymphoma, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..2), H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..3), H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..4), H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..5), H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..6), H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..7), H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..8), H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Non-Hodgkin Lymphoma - Pipeline by 3SBio Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by 4SC AG, H2 2019
Non-Hodgkin Lymphoma - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H2 2019
Non-Hodgkin Lymphoma - Pipeline by AB Science SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by AbbVie Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ABIONYX Pharma SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Abologix Sarl, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Abzena Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ACEA Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Actinium Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Adagene (Suzhou) Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ADC Therapeutics SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Adicet Bio Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Adienne Pharma & Biotech, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Adlai Nortye Biopharma Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Advenchen Laboratories LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Affimed GmbH, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Affitech A/S, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Agios Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by AI Therapeutics, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Akeso Biopharma Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Aleta Biotherapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by AlfaSigma SpA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Allogene Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Alopexx Oncology LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Altor Bioscience LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ALX Oncology Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Amgen Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Anew Oncology Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Angimmune LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Angiocrine Bioscience Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Anhui Anke Biotechnology (Group) Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Apollomics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Apotex Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Applied Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Archigen Biotech Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Argenx SE, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ArQule Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Arrien Pharmaceuticals LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Ascentage Pharma Group International, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Astellas Pharma Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Astex Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by AstraZeneca Plc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by AUM Biosciences Pte Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Aurigene Discovery Technologies Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Autolus Therapeutics Plc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Avalon GloboCare Corp, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Avipep Pty Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Ayala Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by AzarGen Biotechnologies (Pty) Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Bantam Pharmaceutical LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BARcure, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Bayer AG, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BeiGene Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Beijing GD Initiative Cell Therapy Technology Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Beijing Immunochina Medical Science & Technology Co Ltd, H2
Non-Hodgkin Lymphoma - Pipeline by Beijing Immunotech Applied Science Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Beijing Luzhu Biotechnology Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Beijing Mabworks Biotech Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Bellicum Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BendaRx Corp, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Betta Pharmaceuticals Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Bio-Path Holdings Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Bio-Thera Solutions Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Biogen Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BioIntegrator Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BioInvent International AB, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BioLineRx Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Bioniz Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BioPact Ventures LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Biothera Pharmaceutical Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BioXpress Therapeutics SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by BiVictriX Therapeutics Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by bluebird bio Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Boehringer Ingelheim International GmbH, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Boryung Pharmaceutical Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Boryung ViGenCell Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Boston Biomedical Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Brickell Biotech Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Bristol-Myers Squibb Co, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cadila Healthcare Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Carrick Therapeutics Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CARsgen Therapeutics Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cartherics Pty Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CASI Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Catalent Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Catapult Therapeutics BV, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Celdara Medical LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Celgene Corp, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cell Medica Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cell Source Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cell>Point LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CellCentric Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Celldex Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cellectar Biosciences Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cellectis SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Celleron Therapeutics Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cellestia Biotech AG, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Celltrion Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cellular Biomedicine Group Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cellular Biomedicine Group Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Celularity Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Centaurus Biopharma Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Centrose LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CerRx Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CGeneTech (Suzhou China) Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Checkmate Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Checkpoint Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ChemioCare USA Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by China Immunotech Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Chipscreen Biosciences Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CHO Pharma Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Chugai Pharmaceutical Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cielo Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Clayton Biotechnologies Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Clevexel Pharma SAS, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Codiak BioSciences Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Constellation Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Corvus Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CRISPR Therapeutics AG, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CrystalGenomics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CSL Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CSPC Pharmaceutical Group Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CStone Pharmaceuticals Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Curis Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Curocell Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cyclacel Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Cyteir Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by CytomX Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Daiichi Sankyo Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Daysai Biopharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Debiopharm International SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Denovo Biopharma LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Dizal (Jiangsu) Pharmaceutical Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by eFFECTOR Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Eisai Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Eli Lilly and Co, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Epidestiny Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Epizyme Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Erytech Pharma SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Esanex Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Eternity Bioscience Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Eureka Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Eutilex Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Evotec SE, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Exinda Therapeutics LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by F. Hoffmann-La Roche Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Fate Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Formula Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Forty Seven Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Fujifilm Holdings Corp, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Galderma SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Gamida Cell Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by GammaDelta Therapeutics Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by GC Pharma, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Geneius Biotechnology Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Genentech Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Generium, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Generon (Shanghai) Corp Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Genexine Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Genmab A/S, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Genor BioPharma Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Genosco Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Gibson Oncology LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Gilead Sciences Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by GlaxoSmithKline Plc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Gracell Bio, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Grupo Ferrer Internacional SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by GT Biopharma Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by H3 Biomedicine Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Hadasit Medical Research Services and Development Ltd, H2 20
Non-Hodgkin Lymphoma - Pipeline by Hangzhou Hezheng Pharmaceutical Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Hangzhou Minsheng Pharmaceutical Group Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Harbin Gloria Pharmaceuticals Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Hebei Senlang Biotechnology Inc Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by HEC Pharm Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Heidelberg Pharma AG, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Helocyte Biosciences Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by HRAIN Biotechnology Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Hualan Biological Engineering Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Hutchison MediPharma Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by I-Mab Biopharma Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by iBio Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by iCell Gene Therapeutics LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by IGF Oncology LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by IGM Biosciences Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Immune Cell Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ImmuneTarget Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by ImmunoGen Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Immunomedics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Immunomet Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Immunotech Biopharm Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by IMV Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Inatherys, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Incuron LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Incyte Corp, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Inhibrx Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Innate Pharma SA, H2 2019
Non-Hodgkin Lymphoma - Pipeline by InnoCare Pharma Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Innovative Cellular Therapeutics Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Innovent Biologics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by IO Biotech ApS, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Ionis Pharmaceuticals Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Japan Tobacco Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Jazz Pharmaceuticals Plc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by JN Biosciences LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Johnson & Johnson, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Jubilant Biosys Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Juno Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Juventas Cell Therapy Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by JW Therapeutics Shanghai Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Kainos Medicine Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Kangpu Biopharmaceuticals Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Karyopharm Therapeutics Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Kecellitics Biotech Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Klyss Biotech Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Komipharm International Co Ltd, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Kronos Bio Inc, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Kymera Therapeutics LLC, H2 2019
Non-Hodgkin Lymphoma - Pipeline by Kyowa Kirin Co Ltd, H2 2019

List of Figures
Number of Products under Development for Non-Hodgkin Lymphoma, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • 3SBio Inc
  • 4SC AG
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • AB Science SA
  • AbbVie Inc
  • ABIONYX Pharma SA
  • Abologix Sarl
  • Abzena Ltd
  • ACEA Therapeutics Inc
  • Actinium Pharmaceuticals Inc
  • Adagene (Suzhou) Ltd
  • ADC Therapeutics SA
  • Adicet Bio Inc
  • Adienne Pharma & Biotech
  • Adlai Nortye Biopharma Co Ltd
  • Advenchen Laboratories LLC
  • Affimed GmbH
  • Affitech A/S
  • Agios Pharmaceuticals Inc
  • AI Therapeutics
  • Akeso Biopharma Inc
  • Aleta Biotherapeutics Inc
  • AlfaSigma SpA
  • Allogene Therapeutics Inc
  • Alopexx Oncology LLC
  • Altor Bioscience LLC
  • ALX Oncology Inc
  • Amgen Inc
  • Anew Oncology Inc
  • Angimmune LLC
  • Angiocrine Bioscience Inc
  • Anhui Anke Biotechnology (Group) Co Ltd
  • Apollomics Inc
  • Apotex Inc
  • Applied Therapeutics Inc
  • Archigen Biotech Ltd
  • Argenx SE
  • ArQule Inc
  • Arrien Pharmaceuticals LLC
  • Ascentage Pharma Group International
  • Astellas Pharma Inc
  • Astex Pharmaceuticals Inc
  • AstraZeneca Plc
  • AUM Biosciences Pte Ltd
  • Aurigene Discovery Technologies Ltd
  • Autolus Therapeutics Plc
  • Avalon GloboCare Corp
  • Avipep Pty Ltd
  • Ayala Pharmaceuticals Inc
  • AzarGen Biotechnologies (Pty) Ltd
  • Bantam Pharmaceutical LLC
  • BARcure
  • Bayer AG
  • BeiGene Ltd
  • Beijing GD Initiative Cell Therapy Technology Co Ltd
  • Beijing Immunochina Medical Science & Technology Co Ltd
  • Beijing Immunotech Applied Science Ltd
  • Beijing Luzhu Biotechnology Co Ltd
  • Beijing Mabworks Biotech Co Ltd
  • Bellicum Pharmaceuticals Inc
  • BendaRx Corp
  • Betta Pharmaceuticals Co Ltd
  • Bio-Path Holdings Inc
  • Bio-Thera Solutions Ltd
  • Biogen Inc
  • BioIntegrator Ltd
  • BioInvent International AB
  • BioLineRx Ltd
  • Bioniz Therapeutics Inc
  • BioPact Ventures LLC
  • Biothera Pharmaceutical Inc
  • BioXpress Therapeutics SA
  • BiVictriX Therapeutics Ltd
  • bluebird bio Inc
  • Boehringer Ingelheim International GmbH
  • Boryung Pharmaceutical Co Ltd
  • Boryung ViGenCell Inc
  • Boston Biomedical Inc
  • Brickell Biotech Inc
  • Bristol-Myers Squibb Co
  • Cadila Healthcare Ltd
  • Carrick Therapeutics Ltd
  • CARsgen Therapeutics Ltd
  • Cartherics Pty Ltd
  • CASI Pharmaceuticals Inc
  • Catalent Inc
  • Catapult Therapeutics BV
  • Celdara Medical LLC
  • Celgene Corp
  • Cell Medica Ltd
  • Cell Source Inc
  • Cell>Point LLC
  • CellCentric Ltd
  • Celldex Therapeutics Inc
  • Cellectar Biosciences Inc
  • Cellectis SA
Note: Product cover images may vary from those shown
Adroll
adroll